Bone density loss in Crohn's disease: role of TNF and potential for prevention by bupropion
- PMID: 15194665
- PMCID: PMC1774110
Bone density loss in Crohn's disease: role of TNF and potential for prevention by bupropion
Comment on
-
Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study.Gut. 2004 Feb;53(2):251-5. doi: 10.1136/gut.2003.026799. Gut. 2004. PMID: 14724159 Free PMC article.
References
-
- Lichtenstein GR. Evaluation of bone mineral density in IBD: current safty focus. Am J Gastroenterol 2003;98 (suppl 12) :S24–30. - PubMed
-
- Nanes MS. TNF-alpha: molecular and cellular mechanisms in skeletal pathology. Gene 2003;321:1–15. - PubMed
-
- Bingham CO iii. The pathogenesis of rheumatoid arthritis: pivotal cytokines involved in bone degradation and inflammation. J Rheumatol Suppl 2002;65:39. - PubMed
-
- Goldring SR. Pathogenesis of bone and cartilage destruction in rheumatoid arthritis. Rheumatology 2003;42 (suppl 2) :ii11–6. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical